Jaguar Health, Inc. (JAGX) › Operating Cash FlowJaguar Health, Inc. (JAGX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2016: -$14.41M2017: -$9.82M2018: -$22.73M2019: -$20.46M2020: -$15.28M2021: -$34.97M2022: -$33.10M2023: -$33.24M2024: -$29.38M2025: -$23.69M-$23.69M2016Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$23.69M+19.4%2024-$29.38M+11.6%2023-$33.24M-0.4%2022-$33.10M+5.3%2021-$34.97M-128.9%2020-$15.28M+25.3%2019-$20.46M+10.0%2018-$22.73M-131.4%2017-$9.82M+31.8%2016-$14.41M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share